Aspirin MI Primary Prevention Labeling Urged In Bayer Citizen Petition
This article was originally published in The Tan Sheet
Executive Summary
Aspirin therapy led to a statistically significant 32% reduction in first myocardial infarctions among over 55,000 subjects evaluated in a meta-analysis of five primary prevention studies conducted by Bayer Consumer Care
You may also be interested in...
Bayer Seeks To Reinvigorate Aspirin’s Pain Relief Profile
Bayer HealthCare recently launched its “Fast Relief Challenge” campaign to remind consumers about aspirin’s pain relief indication and to highlight Bayer Advanced Aspirin. The firm refers to a survey showing 8% of respondents preferred aspirin more than other OTC pain relievers.
Bayer Seeks To Reinvigorate Aspirin’s Pain Relief Profile
Bayer HealthCare recently launched its “Fast Relief Challenge” campaign to remind consumers about aspirin’s pain relief indication and to highlight Bayer Advanced Aspirin. The firm refers to a survey showing 8% of respondents preferred aspirin more than other OTC pain relievers.
Aspirin Tops Three Rx Drugs In Preventing Heart Attack – Consumers Union
Aspirin is the blood thinning agent of choice over three prescription antiplatelet medications for preventing first or repeat heart attack or stroke, according to a Consumers Union report